The management of chronic kidney disease (CKD) in patients with T2D

Watch multidisciplinary experts discuss key challenges in treating patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). They evaluate the unmet treatment needs, the evidence for using nonsteroidal mineralocorticoid receptor antagonists (MRAs) and how these agents may be incorporated into daily clinical practice.
🔸View the full activity here: bit.ly/3GGqVKV
This activity is funded by an independent medical education grant from Bayer AG. This activity is jointly provided by USF Health and touchIME.
🔸Don't forget to follow touchENDOCRINOLOGY on our other social platforms so you never miss a thing:
Twitter: bit.ly/2ZNuq10
Facebook: bit.ly/3q3gvik
Instagram: bit.ly/3nWBSiG
Linkedin: bit.ly/3mGMovb
Website: bit.ly/3wdNUIn
#CardiovascularRisk #ChronicKidneyDisease #Diabetes #T2D #CKD
#mineralocorticoidreceptors #MRAs